CIBC Private Wealth Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$111K Buy
638
+459
+256% +$83.8K ﹤0.01% 1460
2025
Q3
$25.7K Buy
179
+53
+42% +$6.49K ﹤0.01% 2062
2025
Q2
$12.7K Sell
126
-701
-85% -$53.6K ﹤0.01% 2177
2025
Q1
$53.7K Buy
827
+239
+41% +$18.3K ﹤0.01% 1605
2024
Q4
$38.6K Buy
588
+82
+16% +$5.91K ﹤0.01% 1779
2024
Q3
$36.9K Buy
+506
New +$37.3K ﹤0.01% 1886
2024
Q2
Sell
-15
Closed -$401 3219
2024
Q1
$401 Buy
+15
New +$420 ﹤0.01% 2953

Other funds holding INSM

CIBC Private Wealth Group's INSM Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Insmed (INSM) stake by 256% in Q4 2025, buying an estimated $83.8K and bringing the position to 638 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

CIBC Private Wealth Group first reported a position in INSM in Q1 2024 and has held it in 7 quarters since. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • CIBC Private Wealth Group held 638 shares of Insmed worth $111K as of Q4 2025.
  • CIBC Private Wealth Group bought 459 Insmed shares in Q4 2025, an estimated $83.8K.
  • Insmed made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1460 holding.
  • CIBC Private Wealth Group first reported a position in Insmed in Q1 2024 and has held it in 7 quarters since.
  • 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.